- 全部删除
您的购物车当前为空
APX-115 free base (Ewha-18278 free base) 是口服具有活性的、非选择性的 Nox 抑制剂,对 Nox1,Nox2和 Nox4的 Ki 分别为 1.08 μM,0.57 μM 和 0.63 μM。它能够有效预防糖尿病小鼠的肾损伤。

APX-115 free base (Ewha-18278 free base) 是口服具有活性的、非选择性的 Nox 抑制剂,对 Nox1,Nox2和 Nox4的 Ki 分别为 1.08 μM,0.57 μM 和 0.63 μM。它能够有效预防糖尿病小鼠的肾损伤。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 412 | In stock | |
| 5 mg | ¥ 993 | In stock | |
| 10 mg | ¥ 1,650 | In stock | |
| 25 mg | ¥ 3,480 | In stock | |
| 50 mg | ¥ 4,960 | In stock | |
| 100 mg | ¥ 6,860 | In stock | |
| 200 mg | ¥ 9,250 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 1,190 | In stock |
APX-115 free base 相关产品
| 产品描述 | APX-115 free base (Ewha-18278 free base) (Ewha-18278 free base) is a potent, orally active pan NADPH oxidase (Nox) inhibitor (Kis: 1.08 μM, 0.57 μM, and 0.63 μM for Nox1, Nox2, and Nox4). APX-115 effectively prevents kidney injury. |
| 靶点活性 | Nox4:0.63 μM (ki), NOX2:0.57 μM (ki), NOX1:ki:1.08 μM |
| 体外活性 | In the mouse podocyte cell line, APX-115 free base (5?μM; 60?min) almost completely suppresses high glucose-induced proinflammatory and profibrotic molecule expression. In the kidney, APX-115 free base attenuates Nox gene upregulation and protein expression while improving inflammatory and fibrotic processes [2]. |
| 体内活性 | APX-115 free base treatment decreases the urinary excretion of albumin and plasma creatinine levels. APX-115 (oral gavage; 60?mg/kg/day; for 12 weeks) significantly improves insulin resistance in diabetic mice. |
| 别名 | Ewha-18278 free base |
| 分子量 | 279.34 |
| 分子式 | C17H17N3O |
| CAS No. | 1270084-92-8 |
| Smiles | CCCc1c(O)n(nc1-c1ccccc1)-c1ccccn1 |
| 密度 | 1.17 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 245 mg/mL (877.07 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容